Dyslipidemia

>

Latest News

Despite Improved Screening and Rates of Dyslipidemia, Prescribing Not Yet at Optimal levels
Despite Improved Screening and Rates of Dyslipidemia, Prescribing Not Yet at Optimal levels

January 13th 2023

An analysis of NHANES data from 1999-2018 details the progress made with regard to cholesterol management on a population level but also provides insight into areas where room for improvement still exists.

Icosapent Ethyl May Be Cost Effective in Patients With Hypertriglyceridemia
Icosapent Ethyl May Be Cost Effective in Patients With Hypertriglyceridemia

February 16th 2022

FDA Grants Clearance To Cardiac Mapping System For Cardiac Arrhythmia Treatment
FDA Grants Clearance To Cardiac Mapping System For Cardiac Arrhythmia Treatment

January 12th 2022

FDA Issues CRL for Inclisiran
FDA Issues CRL for Inclisiran

December 18th 2020

Treating Combined High Lipoprotein, Inflammation Reduces MACE Risks
Treating Combined High Lipoprotein, Inflammation Reduces MACE Risks

July 20th 2020

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.